Aldafermin
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Aldafermin, covering 2023-10-12 to 2025-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3) [Phase 2]